People · Operator
Named in public records as an officer, director or promoter · active 2010–2022 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NABsys Inc | — | Biotechnology | Series B | $70.3M | $1.0B | 2010 |
| Invenra Inc. | — | Pharmaceuticals | Series A | $21.3M | $220.8M | 2013 |
| Xeno Biosciences Inc. | — | Biotechnology | Series A | $12.1M | $16.4M | 2021 |
Stan Rose at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stan Rose on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Martirano | 1 | 11 |
| Ray Stata | 1 | 7 |
| David Snyder | 1 | 5 |
| Paul Weiss | 1 | 5 |
| Leroy Hood | 1 | 5 |
| Jeffrey Arnold | 1 | 5 |
| Peter Lewis | 1 | 4 |
| Lionel Carnot | 1 | 3 |
| William Gerber | 1 | 3 |
| Emile Nuwaysir | 1 | 2 |
| John Oliver | 1 | 2 |
| Gina Raimondo | 1 | 2 |
| Richard Lesniewski | 1 | 2 |
| Michael Koeris | 1 | 2 |
| Roland Green | 1 | 1 |
| Barrett Bready | 1 | 1 |
| Steve Lombardi | 1 | 1 |
| David Beno | 1 | 1 |
| Tom Hughes | 1 | 1 |
| Hasan Celiker | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.